IGF2BP3 Human Pre-designed siRNA Set A
Based on 3 publication(s) in Google Scholar
IGF2BP3 Human Pre-designed siRNA Set A contains three designed siRNAs for IGF2BP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) IGF2BP3 Human Pre-designed siRNA Set A
More
Biological Activity
IGF2BP3 Human Pre-designed siRNA Set A contains three designed siRNAs for IGF2BP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
IGF2BP3 siRNA-1: 5 nmol (HPLC)
IGF2BP3 siRNA-2: 5 nmol (HPLC)
IGF2BP3 siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
IGF2BP3 - insulin like growth factor 2 mRNA binding protein 3 Gene (Human)
KOC; CT98; IMP3; KOC1; IMP-3; VICKZ3
Chemical Information
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Ann Hepatol
The promoting effect of the POU3F2/METTL16/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinoma. [Abstract]2025 Jul-Dec;30(2):101776. PMID: 39756795 -
J Biochem Mol Toxicol
Exosomes From Hepatitis B Virus-Infected Hepatocytes Induce Liver Fibrosis Through METTL3-Mediated m6A Modification of P2RX7 mRNA. [Abstract]2025 Dec;39(12):e70645. PMID: 41405154 -
J Biochem Mol Toxicol
METTL3-Mediated m6A Methylation Stabilizes IFI27 to Drive Esophageal Squamous Cell Carcinoma Progression Through an IGF2BP2-Dependent Mechanism. [Abstract]2025 Mar;39(3):e70167. PMID: 39987518
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)